Press releases
- Glaukos Announces First Quarter 2024 Financial Results
- Glaukos Announces the Release of its 2023 Sustainability Report
- Glaukos to Release First Quarter 2024 Financial Results after Market Close on May 1
- Glaukos Receives Permanent J-code for iDose® TR (travoprost intracameral implant)
- Glaukos To Present Numerous Scientific Abstracts at the 2024 American Society of Cataract and Refractive Surgery Annual Meeting
More ▼
Key statistics
As of last trade Glaukos Corp (6GJ:DUS) traded at 98.00, -4.85% below its 52-week high of 103.00, set on May 15, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 98.00 |
---|---|
High | 98.00 |
Low | 98.00 |
Bid | 98.00 |
Offer | 101.00 |
Previous close | 99.50 |
Average volume | 0.00 |
---|---|
Shares outstanding | 50.37m |
Free float | 48.62m |
P/E (TTM) | -- |
Market cap | 5.47bn USD |
EPS (TTM) | -2.88 USD |
Data delayed at least 15 minutes, as of May 23 2024 07:10 BST.
More ▼